| Schedule of earnings per share, basic and diluted |
The following is a summary of the basic and diluted net loss per share computation for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | (In thousands, except share and per share data) | | 2026 | | 2025 | | 2026 | | 2025 | | Income (loss) from continuing operations | | $ | 1,015 | | | $ | (31,858) | | | $ | (7,346) | | | $ | (127,026) | | | Preferred stock dividends | | (10,936) | | | (10,936) | | | (21,872) | | | (21,872) | | | Adjustments to net loss attributable to common stockholders for common share equivalents | | (329) | | | (599) | | | (866) | | | (946) | | | Adjusted net loss attributable to common stockholders - Continuing Operations | | (10,250) | | | (43,393) | | | (30,084) | | | (149,844) | | | Income (loss) from discontinued operations | | 2,471 | | | 7,715 | | | 5,754 | | | (86,496) | | | Adjusted net loss attributable to common stockholders | | $ | (7,779) | | | $ | (35,678) | | | $ | (24,330) | | | $ | (236,340) | | | | | | | | | | | | | | | | | | | | | Weighted average common shares outstanding — Basic and Diluted | | 211,338,853 | | | 222,960,030 | | | 212,681,722 | | | 226,591,693 | | | | | | | | | | | | Net loss from continuing operations — Basic and Diluted | | $ | (0.05) | | | $ | (0.19) | | | $ | (0.14) | | | $ | (0.66) | | | Net income (loss) from discontinued operations — Basic and Diluted | | 0.01 | | | 0.03 | | | 0.03 | | | (0.38) | | | Net loss per share attributable to common stockholders — Basic and Diluted | | $ | (0.04) | | | $ | (0.16) | | | $ | (0.11) | | | $ | (1.04) | |
|
| Schedule of antidilutive securities excluded from computation of earnings per share |
The following table shows common share equivalents on a weighted average basis that were excluded from the calculation of diluted earnings per share for the three and six months ended June 30, 2026 and 2025 (see Note 12 — Equity-Based Compensation for additional information on all of the common share equivalents listed in the table below): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Unvested RSUs (1) | | 1,835,513 | | | 1,885,808 | | | 1,914,793 | | | 1,815,148 | | Unvested Restricted Shares (2) | | 132,425 | | | 267,269 | | | 150,440 | | | 298,119 | | Unvested PSUs (3) | | 4,757,021 | | | 3,165,179 | | | 4,739,432 | | | 3,030,359 | | | Total common share equivalents excluded from calculation | | 6,724,959 | | | 5,318,256 | | | 6,804,665 | | | 5,143,626 | |
(1) There were 1,794,729 and 1,871,118 unvested RSUs issued and outstanding as of June 30, 2026 and 2025, respectively. (2) There were 68,727 and 170,198 unvested Restricted Shares issued and outstanding as of June 30, 2026 and 2025, respectively. (3) There were 4,757,021 PSUs outstanding as of June 30, 2026 and 3,165,179 outstanding as of June 30, 2025.
|